Legency Remedies Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Legency Remedies Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $554.4K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Legency Remedies Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $554.4K Trade | TransData Nexus

Legency Remedies Private Limited

Indian Pharmaceutical Exporter · Respiratory Specialist · $554.4K Total Trade · DGFT Verified

Legency Remedies Private Limited is an Indian pharmaceutical exporter with a total trade value of $554.4K across 2 products in 1 therapeutic categories. Based on 47 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Budesonide ($333.0K), Ipratropium ($221.4K), .

Legency Remedies Private Limited — Export Portfolio & Destination Treemap

Legency Remedies Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Legency Remedies Private Limited? — Company Overview & Market Position

Legency Remedies Private Limited, established on February 28, 2005, is a privately held pharmaceutical company headquartered in Baddi, Himachal Pradesh, India. The company is registered under the Corporate Identification Number (CIN) U24230HP2005PTC030847. As of the latest available data, Legency Remedies has an authorized capital of ₹10 million and a paid-up capital of ₹9.3 million. The company employs approximately 73 professionals. Its manufacturing facility is located at Village Katha, Tehsil Nalagarh, Baddi, Himachal Pradesh, 173205.

What Does Legency Remedies Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Budesonide$333.0K 2Ipratropium$221.4K

Legency Remedies Private Limited Therapeutic Categories — 1 Specializations

Legency Remedies Private Limited operates across 1 therapeutic categories, with representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.

Product Portfolio — Top 2 by Export Value

Legency Remedies Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Budesonide	Respiratory	$333.0K	31	0.2%	14
2	Ipratropium	Respiratory	$221.4K	16	0.4%	10

Legency Remedies Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $554.4K. The top category is Respiratory (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Legency Remedies Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Legency Remedies operates a state-of-the-art manufacturing plant in Baddi, Himachal Pradesh, designed to meet global regulatory standards. The facility specializes in the production of small volume parenterals, including intravenous fluids ranging from 2ml to 50ml. It has a production capacity of one crore ampoules per month. The plant has been approved for export to countries such as Sri Lanka, Ethiopia, the Philippines, and other African nations.

3Key Leadership

The leadership team at Legency Remedies Private Limited comprises:

Ravi Goyal – Director, appointed on August 19, 2016.
Raman Goyal – Director, appointed on July 11, 2007.
Manoj Kumar Jain – Director, appointed on July 11, 2007.

These directors oversee the strategic and operational aspects of the company.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Legency Remedies Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Legency Remedies Private Limited has made significant strides in regulated markets, particularly in the production of respiratory solutions. The company's manufacturing facility is WHO-GMP certified, ensuring compliance with international quality standards. This certification facilitates access to markets in Sri Lanka, Ethiopia, the Philippines, and other African countries. However, specific details regarding regulatory filings, approvals, and market access in the US, EU, UK, Australia, and Japan are not publicly available.

2Emerging Markets

Legency Remedies has expanded its presence in emerging markets, particularly in Africa and Southeast Asia. The WHO-GMP certification of its manufacturing facility has enabled the company to export products to countries such as Sri Lanka, Ethiopia, and the Philippines. This certification ensures that the company's products meet international quality standards, facilitating smoother market entry and acceptance.

3Geographic Strategy

Legency Remedies Private Limited's geographic strategy appears to be focused on expanding its footprint in emerging markets, particularly in Africa and Southeast Asia. The WHO-GMP certification of its manufacturing facility has enabled the company to export products to countries such as Sri Lanka, Ethiopia, and the Philippines. This strategic direction suggests a deliberate effort to diversify its market presence and reduce dependence on any single region.

Legency Remedies Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Legency Remedies Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's focus on WHO-GMP certification indicates a commitment to meeting international quality standards, which may facilitate entry into regulated markets.

2WHO & EU GMP

Legency Remedies Private Limited's manufacturing facility is certified by the World Health Organization's Good Manufacturing Practice (WHO-GMP), ensuring compliance with international quality standards. This certification facilitates access to markets in Sri Lanka, Ethiopia, the Philippines, and other African countries. However, specific details regarding EU GMP certification or EDQM status are not publicly available.

3CDSCO & Indian Regulatory

Legency Remedies Private Limited holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company's manufacturing facility is located in Baddi, Himachal Pradesh, a region known for its pharmaceutical manufacturing capabilities. Specific details regarding state drug controller approvals and export No Objection Certificates (NOCs) are not publicly available.

Legency Remedies Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Legency Remedies Private Limited operates in the competitive pharmaceutical industry, focusing on the production of respiratory solutions and small volume parenterals. While specific competitors in overlapping categories are not publicly identified, the company's WHO-GMP certification and export approvals to countries such as Sri Lanka, Ethiopia, and the Philippines suggest a competitive position in emerging markets.

2Key Differentiators

Legency Remedies Private Limited's key differentiators include its WHO-GMP certified manufacturing facility, enabling access to regulated markets, and its focus on respiratory solutions and small volume parenterals. The company's production capacity of one crore ampoules per month and its export approvals to countries such as Sri Lanka, Ethiopia, and the Philippines further distinguish it in the market.

3Strategic Position

Legency Remedies Private Limited's current strategic direction focuses on expanding its presence in emerging markets, particularly in Africa and Southeast Asia. The company's WHO-GMP certification and export approvals to countries such as Sri Lanka, Ethiopia, and the Philippines support this strategy. Future outlooks may involve further diversification of its product portfolio and exploration of additional regulated markets.

Buyer Due Diligence Brief — Evaluating Legency Remedies Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Legency Remedies Private Limited demonstrates a strong track record in manufacturing and exporting pharmaceutical products. The company's WHO-GMP certified facility and production capacity of one crore ampoules per month indicate reliability and consistency in its operations. Export approvals to countries such as Sri Lanka, Ethiopia, and the Philippines further attest to the company's credibility as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Legency Remedies Private Limited as a supplier:

WHO-GMP Certification: Ensures compliance with international manufacturing standards. Verification can be obtained by contacting the company directly or through the World Health Organization's official channels.

ISO Certifications: Indicate adherence to quality management systems. Verification can be obtained by contacting the company directly or through the International Organization for Standardization's official channels.

Frequently Asked Questions — Legency Remedies Private Limited

How many pharmaceutical products does Legency Remedies Private Limited export from India?

Legency Remedies Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Budesonide ($333.0K), Ipratropium ($221.4K). Total export value is $554.4K.

What is Legency Remedies Private Limited's total pharmaceutical export value?

Legency Remedies Private Limited's total pharmaceutical export value is $554.4K, based on 47 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Legency Remedies Private Limited cover?

Legency Remedies Private Limited exports across 1 therapeutic categories. The largest are Respiratory (100.0%, 2 products).

Get Full Legency Remedies Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.